| Market Cap | 7.05M | P/E | - | EPS this Y | 97.10% | Ern Qtrly Grth | - |
| Income | -10.03M | Forward P/E | -5.26 | EPS next Y | 65.90% | 50D Avg Chg | -3.00% |
| Sales | 2.83M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -30.00% |
| Dividend | N/A | Price/Book | 1.06 | EPS next 5Y | - | 52W High Chg | -84.00% |
| Recommedations | 1.00 | Quick Ratio | 1.78 | Shares Outstanding | 2.84M | 52W Low Chg | 31.00% |
| Insider Own | 1.46% | ROA | -45.62% | Shares Float | 3.08M | Beta | - |
| Inst Own | 7.54% | ROE | -118.96% | Shares Shorted/Prior | 73.49K/90.99K | Price | 0.47 |
| Gross Margin | 23.33% | Profit Margin | - | Avg. Volume | 52,868 | Target Price | 12.00 |
| Oper. Margin | -358.55% | Earnings Date | - | Volume | 9,030 | Change | -1.58% |
Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Sakiris Spiro Kevin | Chief Financial Offi.. Chief Financial Officer | Jun 22 | Buy | 0.6498 | 5,000 | 3,249 | 50,228 | 06/24/22 |
| Sakiris Spiro Kevin | ChiefFinancial Offic.. ChiefFinancial Officer | Jun 17 | Buy | 0.6115 | 15,970 | 9,766 | 45,228 | 06/22/22 |
| Life Science Biosensor Diagnos... | - - | Feb 17 | Sell | 0.51 | 576,028 | 293,774 | 1,081,804 | 02/22/22 |
| Life Science Biosensor Diagnos... | 10% Owner 10% Owner | Feb 16 | Sell | 0.63 | 100,000 | 63,000 | 1,657,832 | 02/18/22 |
| Life Science Biosensor Diagnos... | 10% Owner 10% Owner | Feb 11 | Sell | 0.71 | 300,000 | 213,000 | 1,757,832 | 02/17/22 |
| Life Science Biosensor Diagnos... | 10% Owner 10% Owner | Feb 10 | Sell | 0.84 | 100,000 | 84,000 | 2,057,832 | 02/15/22 |
| Life Science Biosensor Diagnos... | 10% Owner 10% Owner | Feb 09 | Sell | 0.86 | 100,000 | 86,000 | 2,157,832 | 02/11/22 |
| Life Science Biosensor Diagnos... | 10% Owner 10% Owner | Feb 08 | Sell | 0.89 | 100,000 | 89,000 | 2,257,832 | 02/10/22 |
| Life Science Biosensor Diagnos... | 10% Owner 10% Owner | Feb 02 | Sell | 0.92 | 100,000 | 92,000 | 2,357,832 | 02/08/22 |
| Life Science Biosensor Diagnos... | 10% Owner 10% Owner | Jan 31 | Sell | 0.90 | 100,000 | 90,000 | 2,457,832 | 02/03/22 |
| Life Science Biosensor Diagnos... | 10% Owner 10% Owner | Jan 28 | Sell | 0.92 | 100,000 | 92,000 | 2,557,832 | 02/01/22 |
| Life Science Biosensor Diagnos... | 10% Owner 10% Owner | Jan 27 | Sell | 1.00 | 100,000 | 100,000 | 2,657,832 | 02/01/22 |